Close
Novotech

Drug Research

Pfizer And Moderna Omicron Kid Boosters Approved By FDA

Following a decision by the Food and Drug Administration to broaden its authorization of reformulated shots from Moderna and partners Pfizer and BioNTech, kids as young as 5 years old can now receive an updated COVID-19 booster. The vaccine...

Stanford Scientists Devise A Breakthrough Cancer Treatment

The molecule tigilanol tiglate, also known as EBC-46, could provide tailored treatment for diseases including cancer, as according research from Stanford University in the US that was recently published in the scientific journal Nature Chemistry. The chemical is only naturally...

Collaboration Between Ziphius and UZ Ghent on Vaccination

A public-private partnership between UZ Ghent and Ziphius Vaccines, a firm producing vaccines and treatments based on self-amplifying RNA (saRNA), has been announced. The collaboration entails scaling up and producing prophylactic self-amplifying RNA vaccines in accordance with GMP guidelines. The...

The User Fees Have Been Authorised Yet Again At The FDA

As anticipated, four important user fee programmes were renewed by Congress for the week ending October 1st as part of a bill that was required to pass in order to finance the government for yet another two months. By...

Junk DNA Could Be The Key To Understanding Neuro Ailments

According to recent studies, there is a connection between non-coding DNA and some neurological diseases such as Alzheimer's and motor neurone disease. Researchers from the Universities of Sheffield and Lincoln studied how oxidative breaks in so-called junk DNA are created...

To Accredit Medical Devices In The UK, MHRA Selects DEKRA

The three current UK-approved bodies have been joined by DEKRA Certification UK, according to the Medicines and Healthcare Products Regulatory Agency (MHRA), enhancing the UK's capacity to handle conformity evaluations for medical devices. As the first institution to accomplish...

FDA Expanding Patient Participation In Drug Development

The FDA started a programme ten years ago to increase the role of patients in educating sponsors and regulators on the most detrimental impacts of a condition and the main treatment objectives that can result in desired medical methods....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »